What is Biofrontera Inc (BFRI) stock price today?

Biofrontera Inc (BFRI) currently trades at $1.08 per share. The stock has a market capitalization of $12.58M and a P/E ratio of —x.

Is BFRI stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Biofrontera Inc has a Smart Value Score of 48/100 (Grade C), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Biofrontera Inc's revenue and earnings?

Biofrontera Inc has trailing twelve-month (TTM) revenue of $41.70M with profit margins of -25.30%. Earnings per share (EPS) is $-1.04.

BFRI

Biofrontera Inc

NASDAQ: BFRI · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$1.08

-1.82% today

Updated 2026-04-30

Market cap

$12.58M

P/E ratio

—

P/S ratio

0.30x

EPS (TTM)

$-1.04

Dividend yield

—

52W range

$1 – $1

Volume

0.1M

Market cap

$12.58M

P/E ratio

—

P/S ratio

0.30x

EPS (TTM)

$-1.04

Dividend yield

—

52W range

$1 – $1

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: C

Sell

Investment rating

7.3

Growth

B+

5.0

Quality

C+

4.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$6.00

+455.56%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 36.20% QoQ

Risks

- Thin margins at -25.30%

- Negative free cash flow $-2.38M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$28.67M	$34.07M	$37.30M	$41.70M	$41.70M
Net income	$-640000.00	$-20.13M	$-17.76M	$-10.54M	$5.64M
EPS	—	—	—	—	$-1.04
Free cash flow	$-16.24M	$-24.90M	$-10.33M	$-13.36M	$-2.38M
Profit margin	-2.23%	-59.09%	-47.61%	-25.26%	-25.30%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
BFRI	$12.58M	48	7.3	4.0	5.0	5.0	—	Hold
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Biofrontera Inc trades at $1.08. Our Smart Value Score of 48/100 indicates the stock is fair. TTM revenue stands at $41.70M. with profit margins at -25.30%.

Frequently asked questions

What is Biofrontera Inc's stock price?

Biofrontera Inc (BFRI) trades at $1.08.

Is Biofrontera Inc overvalued?

Smart Value Score 48/100 (Grade C, Sell).

What is the price target of Biofrontera Inc (BFRI)?

The analyst target price is $6.00, representing +455.6% upside from the current price of $1.08.

What is Biofrontera Inc's revenue?

TTM revenue is $41.70M.

Company info

SectorHEALTHCARE

IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio0.30x

ROE-141.30%

Beta0.64

50D MA$0.92

200D MA$0.91

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

BFRI vs LLY →BFRI vs JNJ →BFRI vs ABBV →Stock screener →